NCT07714928

Brief Summary

The goal of this randomized clinical trial is to determine whether Bispectral Index (BIS)-guided general anesthesia improves postoperative cognitive recovery and overall quality of recovery in adults undergoing elective hand or arm surgery. The main questions it aims to answer are: Does BIS-guided anesthesia improve postoperative cognitive recovery compared with general anesthesia guided by routine clinical signs? Does BIS-guided anesthesia improve overall postoperative recovery, as measured by the Postoperative Quality of Recovery Scale (PQRS)? Researchers will compare patients receiving BIS-guided general anesthesia with patients receiving clinically guided general anesthesia, in which the BIS monitor records data but the displayed values are concealed from the anesthesia team, to determine whether BIS-guided anesthetic management improves postoperative recovery. An additional comparison group will consist of patients undergoing surgery under intravenous regional anesthesia without general anesthesia. Participants will: undergo elective hand or arm surgery; receive either BIS-guided or clinically guided general anesthesia, or intravenous regional anesthesia without general anesthesia; complete PQRS assessments before surgery and at multiple postoperative time points, including follow-up for up to three months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 23, 2015

Completed
9.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2024

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

July 7, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 20, 2026

Completed
Last Updated

July 20, 2026

Status Verified

January 1, 2015

Enrollment Period

9.4 years

First QC Date

July 7, 2026

Last Update Submit

July 14, 2026

Conditions

Keywords

bispectraindexsevofluraneanesthesiaelderlycognition

Outcome Measures

Primary Outcomes (1)

  • Participants With Cognitive Recovery at 48 Hours

    Cognitive recovery was assessed using the cognitive domain of the Postoperative Quality of Recovery Scale (PQRS). The domain included orientation, forward digit recall, backward digit recall, word recall, and word generation. Each participant's postoperative performance was compared with that participant's preoperative baseline using the PQRS recovery criteria. A participant was classiMed as cognitively recovered when all applicable cognitive subtests met the recovery criteria. The outcome was reported as the number and percentage of participants cognitively recovered

    48 hours after surgery

Secondary Outcomes (8)

  • Participants With Cognitive Recovery at Other Postoperative Time Points

    20 minutes, 40 minutes, 24 hours, 14 days, and 90 days after surgery

  • Participants With Overall Postoperative Quality of Recovery

    20 minutes, 40 minutes, 24 hours, 48 hours, 14 days, and 90 days after surgery

  • Meeting PQRS Physiological Recovery Criteria

    Immediately after emergence and at 20 and 40 minutes after surgery

  • Postoperative Pain Severity Assessed With PQRS

    Baseline and 20 minutes, 40 minutes, 24 hours, 48 hours, 14 days, and 90 days after surgery

  • Participants Meeting PQRS Emotional Rcovery Criteria

    Baseline and 20 minutes, 40 minutes, 24 hours, 48 hours, 14 days, and 90 days after surgery

  • +3 more secondary outcomes

Study Arms (2)

BIS-Guided General Anesthesia

EXPERIMENTAL

Participants scheduled for general anesthesia were randomized to anesthesia guided by visible Bispectral Index monitoring. The anesthesia team adjusted anesthetic delivery using a target BIS range of 40 to 60. General anesthesia was induced with propofol and maintained with a volatile anesthetic and remifentanil according to the study protocol.

Procedure: BIS-Guided General Anesthesia

Clinically Guided General Anesthesia

ACTIVE COMPARATOR

Participants scheduled for general anesthesia were randomized to anesthesia guided by routine clinical signs. BIS monitoring was connected and recorded throughout anesthesia, but the BIS display was concealed from the anesthesia personnel and was not used to guide anesthetic delivery. The anesthetic regimen otherwise followed the same study protocol as the BIS-guided group.

Procedure: Clinically Guided General Anesthesia

Interventions

General anesthesia was guided by visible Bispectral Index monitoring. Anesthetic delivery was adjusted to maintain a BIS value between 40 and 60. The protocol included propofol for induction and remifentanil with a volatile anesthetic for maintenance.

BIS-Guided General Anesthesia

General anesthesia was guided by routine clinical indicators of anesthetic depth. BIS monitoring was recorded, but its values were concealed from the anesthesia personnel and were not used to adjust anesthetic delivery. The anesthetic regimen otherwise followed the same protocol as the BIS-guided group.

Clinically Guided General Anesthesia

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age 65 years or older.
  • Scheduled to undergo hand or arm surgery using either intravenous regional anesthesia or general anesthesia.
  • Able to understand the study information and provide informed consent.
  • Able to complete the Postoperative Quality of Recovery Scale assessments and cognitive tests.

You may not qualify if:

  • Inability to complete the recovery or cognitive assessments.
  • Deafness or hearing impairment that prevented completion of the assessments.
  • Bispectral Index monitoring could not be applied or used because of technical or surgical reasons.
  • Expected duration of surgery of less than 30 minutes or more than 4 hours.
  • Allergy to nuts or soybeans in participants scheduled to receive general anesthesia.
  • Pregnancy.
  • Substance abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Örebro University Hospital

Örebro, 70185, Sweden

Location

Related Publications (4)

  • Newman S, Wilkinson DJ, Royse CF. Assessment of early cognitive recovery after surgery using the Post-operative Quality of Recovery Scale. Acta Anaesthesiol Scand. 2014 Feb;58(2):185-91. doi: 10.1111/aas.12234. Epub 2013 Nov 22.

  • Royse CF, Newman S, Chung F, Stygall J, McKay RE, Boldt J, Servin FS, Hurtado I, Hannallah R, Yu B, Wilkinson DJ. Development and feasibility of a scale to assess postoperative recovery: the post-operative quality recovery scale. Anesthesiology. 2010 Oct;113(4):892-905. doi: 10.1097/ALN.0b013e3181d960a9.

  • Chan MT, Cheng BC, Lee TM, Gin T; CODA Trial Group. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013 Jan;25(1):33-42. doi: 10.1097/ANA.0b013e3182712fba.

  • Jildenstal P, Eriksson J, Warren Stomberg M, Jakobsson JG. Evaluation of the Postoperative Quality of Recovery Scale test and re-test in Swedish among healthy volunteers. F1000Res. 2016 Oct 21;5:2549. doi: 10.12688/f1000research.9740.1. eCollection 2016.

MeSH Terms

Conditions

Emergence DeliriumPostoperative Cognitive Complications

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental DisordersCognitive DysfunctionCognition Disorders

Study Officials

  • Pether Jildenstål, PhD, Professor

    Department of Anesthesia and intensivecare University Hospital Örebro

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
In the clinically guided general-anesthesia group, BIS values were recorded but concealed from the anesthesia personnel. In the BISguided group, the anesthesia personnel could see the BIS values and use them to guide anesthetic delivery. The anesthesia care provider was therefore aware of the assigned management strategy. Participants were under general anesthesia during the intervention. The available protocol documents do not clearly establish whether investigators or postoperative PQRS outcome assessors remained unaware of treatment allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Three parallel groups were studied. Patients whose planned surgery was to be performed under intravenous regional anesthesia entered a nonrandomized regional-anesthesia comparison group. Patients scheduled for general anesthesia were randomized using sealed envelopes to either BIS-guided anesthesia, targeting a Bispectral Index value of 40 to 60, or clinically guided anesthesia in which BIS values were recorded but concealed from the anesthesia personnel.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2026

First Posted

July 20, 2026

Study Start

January 23, 2015

Primary Completion

June 10, 2024

Study Completion

June 10, 2024

Last Updated

July 20, 2026

Record last verified: 2015-01

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the original participant consent and ethics documentation did not include a prospective plan for external sharing of participant-level data. Study data are coded and access is restricted to the authorized research team. Results will be reported in aggregated form. Any future request for data access would require separate review and approval by the study sponsor, data controller, and relevant ethics and data-protection authorities.

Locations